Insider Trading activities at Reshape Lifesciences Inc. (RSLS)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Reshape Lifesciences Inc. (RSLS) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Reshape Lifesciences Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1427570.

Total stock buying since 2016: $7,125,183.
Total stock sales since 2016: $9,418,484.
Total stock option exercises since 2016: $26,510.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Reshape Lifesciences Inc.* (*RSLS*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2024	0	$0	91	$19	0	$0
2023	17,702	$26,907	1,343	$5,009	0	$0
2022	20,000	$18,200	506,460	$175,626	0	$0
2021	50,000	$140,120	2,898,110	$9,237,830	0	$0
2019	408,750	$1,482,835	0	$0	0	$0
2018	2,837,205	$5,241,121	0	$0	20,576	$26,510
2016	14,400	$216,000	0	$0	0	$0

Table 2. Monthly summary of insider trading at *Reshape Lifesciences Inc.* (*RSLS*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2024-05	0	$0	48	$12	0	$0
2024-02	0	$0	43	$7	0	$0
2023-12	0	$0	42	$10	0	$0
2023-11	0	$0	39	$8	0	$0
2023-10	0	$0	170	$71	0	$0
2023-09	0	$0	118	$105	0	$0
2023-08	0	$0	147	$209	0	$0
2023-07	0	$0	106	$155	0	$0
2023-06	17,702	$26,907	0	$0	0	$0
2023-05	0	$0	98	$236	0	$0
2023-04	0	$0	96	$226	0	$0
2023-03	0	$0	109	$283	0	$0
2023-02	0	$0	260	$2,523	0	$0
2023-01	0	$0	158	$1,183	0	$0
2022-12	0	$0	7,357	$1,110	0	$0
2022-11	0	$0	373,149	$64,290	0	$0
2022-10	0	$0	8,293	$2,330	0	$0
2022-09	0	$0	4,828	$1,882	0	$0
2022-08	0	$0	16,402	$7,708	0	$0
2022-07	0	$0	16,072	$8,839	0	$0
2022-06	0	$0	15,787	$15,098	0	$0
2022-05	20,000	$18,200	15,946	$12,278	0	$0
2022-04	0	$0	16,101	$18,193	0	$0
2022-02	0	$0	10,196	$10,807	0	$0

Table 3. Detailed insider trading at *Reshape Lifesciences Inc.* (*RSLS*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2024-05-31	Stankovich Thomas (Chief Financial Officer)	Sale	48	.25	12
2024-02-29	Stankovich Thomas (Chief Financial Officer)	Sale	43	.17	7
2023-12-31	Stankovich Thomas (Chief Financial Officer)	Sale	42	.25	10
2023-11-30	Stankovich Thomas (Chief Financial Officer)	Sale	39	.23	8
2023-10-25	Stankovich Thomas (Chief Financial Officer)	Sale	131	.27	35
2023-10-11	Stankovich Thomas (Chief Financial Officer)	Sale	39	.93	36
2023-09-01	Stankovich Thomas (Chief Financial Officer)	Sale	118	.89	105
2023-08-24	Stankovich Thomas (Chief Financial Officer)	Sale	39	1.42	55
2023-08-04	Stankovich Thomas (Chief Financial Officer)	Sale	108	1.43	154
2023-07-06	Stankovich Thomas (Chief Financial Officer)	Sale	106	1.47	155
2023-06-30	Stankovich Thomas (Chief Financial Officer)	Buy	17,702	1.52	26,907
2023-05-31	Stankovich Thomas (Chief Financial Officer)	Sale	98	2.41	236
2023-04-30	Stankovich Thomas (Chief Financial Officer)	Sale	96	2.36	226
2023-03-31	Stankovich Thomas (Chief Financial Officer)	Sale	109	2.60	283
2023-02-28	Stankovich Thomas (Chief Financial Officer)	Sale	103	4.25	437
2023-02-02	Stankovich Thomas (Chief Financial Officer)	Sale	157	13.29	2,086
2023-01-24	Stankovich Thomas (Chief Financial Officer)	Sale	158	7.49	1,183
2022-12-01	Stankovich Thomas (Chief Financial Officer)	Sale	7,357	.15	1,110
2022-11-28	Stankovich Thomas (Chief Financial Officer)	Sale	364,756	.17	62,008
2022-11-04	Stankovich Thomas (Chief Financial Officer)	Sale	8,393	.27	2,282
2022-10-04	Stankovich Thomas (CFO)	Sale	8,293	.28	2,330
2022-09-06	Stankovich Thomas (Chief Financial Officer)	Sale	4,828	.39	1,882
2022-08-05	Bandy Barton P. (President and CEO)	Sale	11,674	.47	5,486
2022-08-05	Stankovich Thomas (Chief Financial Officer)	Sale	4,728	.47	2,222
2022-07-01	Bandy Barton P. (President and CEO)	Sale	11,442	.55	6,293
2022-07-01	Stankovich Thomas (Chief Financial Officer)	Sale	4,630	.55	2,546
2022-06-01	Bandy Barton P. (President and CEO)	Sale	11,309	.95	10,800
2022-06-01	Stankovich Thomas (Chief Financial Officer)	Sale	4,478	.96	4,298
2022-05-31	Stankovich Thomas (Chief Financial Officer)	Buy	20,000	.91	18,200
2022-05-05	Bandy Barton P. (President and CEO)	Sale	11,417	.77	8,791
2022-05-05	Stankovich Thomas (Chief Financial Officer)	Sale	4,529	.77	3,487
2022-04-01	Bandy Barton P. (President and CEO)	Sale	11,063	1.13	12,501
2022-04-01	Stankovich Thomas (Chief Financial Officer)	Sale	5,038	1.13	5,692
2022-02-28	Bandy Barton P. (President and CEO)	Sale	6,538	1.06	6,930
2022-02-28	Stankovich Thomas (CFO)	Sale	3,658	1.06	3,877
2022-01-31	Bandy Barton P. (President and CEO)	Sale	8,324	1.22	10,155
2022-01-31	Stankovich Thomas (Chief Financial Officer)	Sale	3,684	1.22	4,494
2022-01-04	Bandy Barton P. (President and CEO)	Sale	7,150	1.79	12,798
2022-01-04	Stankovich Thomas (Chief Financial Officer)	Sale	3,171	1.78	5,644
2021-12-02	Bandy Barton P. (President and CEO)	Sale	13,427	1.83	24,571
2021-12-02	Stankovich Thomas (Chief Financial Officer)	Sale	4,304	1.83	7,863
2021-11-18	Stankovich Thomas (Chief Financial Officer)	Buy	20,000	2.02	40,400
2021-11-02	Bandy Barton P. (President and CEO)	Sale	13,505	2.69	36,328
2021-11-02	Stankovich Thomas (Chief Financial Officer)	Sale	4,320	2.69	11,620
2021-10-01	Bandy Barton P. (President and CEO)	Sale	12,565	2.77	34,805
2021-10-01	Stankovich Thomas (Chief Financial Officer)	Sale	3,660	2.76	10,101
2021-09-10	Bandy Barton P. (President and CEO)	Sale	294,494	2.89	851,087
2021-09-10	Gladney Dan W (Director)	Sale	200,000	2.99	598,000
2021-09-10	Stankovich Thomas (Chief Financial Officer)	Sale	48,366	2.89	139,777
2021-08-30	Stankovich Thomas (Chief Financial Officer)	Buy	15,000	3.43	51,435
2021-08-20	Stankovich Thomas (Chief Financial Officer)	Buy	15,000	3.22	48,285
2021-06-18	Boyd Steven	Sale	685,583	2.74	1,878,497
2021-06-17	Boyd Steven	Sale	1,106,210	3.33	3,686,997
2021-06-16	Boyd Steven	Sale	511,676	3.83	1,958,184
2019-11-12	Plovanic William J. (President & CEO)	Buy	65,000	1.66	107,835
2019-08-06	Macdonald Robert J (Chief Retail Officer)	Buy	5,000	4.00	20,000
2019-08-06	Plovanic William J. (President & CFO)	Buy	12,500	4.00	50,000
2019-08-06	Vandenberg Amy (Chief Clinical & Reg Officer)	Buy	2,500	4.00	10,000
2019-08-06	Hussainy Nooshin (VP of Finance)	Buy	5,000	4.00	20,000
2019-08-06	Stevenson Sharon	Buy	7,500	4.00	30,000
2019-08-06	Kamdar Kim P. (Director)	Buy	12,500	4.00	50,000
2019-08-06	Halak Brian K (10% Owner)	Buy	250,000	4.00	1,000,000
2019-08-06	Rasdal Andrew P (Exec Chairman of the Board)	Buy	12,500	4.00	50,000
2019-08-06	Brister Mark (Chief Technology Officer)	Buy	5,000	4.00	20,000
2019-08-06	Nasr Khaled (10% Owner)	Buy	25,000	4.00	100,000
2019-08-06	Howe Lesley H	Buy	6,250	4.00	25,000
2018-08-23	Kamdar Kim P. (Director)	Buy	54,945	1.82	99,999
2018-08-23	Halak Brian K (10% Owner)	Buy	1,648,359	1.82	3,000,013
2018-08-23	Nasr Khaled (10% Owner)	Buy	1,098,901	1.82	1,999,999
2018-03-15	Drake Neil (VP Research and Development)	Buy	5,000	3.96	19,780
2018-03-14	Plovanic William J. (Chief Financial Officer)	Buy	10,712	4.04	43,233
2018-03-13	Plovanic William J. (Chief Financial Officer)	Buy	19,288	4.05	78,097
2018-02-02	Drake Neil (VP Research and Development)	Option Ex	13,926	1.42	19,747
2018-01-29	Vandenberg Amy (VP of Reg. and Clin. Affairs)	Option Ex	6,650	1.02	6,763
2016-10-12	Norwood Matthew (VP of Sales)	Buy	1,000	15.00	15,000
2016-10-12	Kamdar Kim P. (Director)	Buy	13,400	15.00	201,000

Insider trading activities including stock purchases, stock sales, and option exercises of RSLS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Reshape Lifesciences Inc. (symbol RSLS, CIK number 1427570) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month